Log in
Enquire now
Sequence Bio

Sequence Bio

Sequence Bio is a biotechnology company combining genomic, multi-omic population data and longitudinal health records from the unique founder population of Newfoundland and Labrador, Canada to find drug targets.

OverviewStructured DataIssuesContributors

Contents

TimelineTable: Funding RoundsTable: ProductsTable: AcquisitionsTable: SBIR/STTR AwardsTable: PatentsTable: Further ResourcesReferences
sequencebio.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Engineering
Engineering
Genomics
Genomics
Drug discovery
Drug discovery
Biomedical engineering
Biomedical engineering
Biopharmaceutical
Biopharmaceutical
Loading...
Genetics
Genetics
Technology
Technology
...
Location
St. John's, Newfoundland and Labrador
St. John's, Newfoundland and Labrador
8
B2X
B2B
B2B
CEO
Chris C Gardner
Chris C Gardner
Founder
Jeremy Grushcow
Jeremy Grushcow
Chris C Gardner
Chris C Gardner
2
AngelList URL
angel.co/sequence-bio
Pitchbook URL
pitchbook.com/profiles...120583-99
Accelerator
Y Combinator
Y Combinator
2
Accelerator Batch
‌
Y Combinator S19 Batch
2
Date Incorporated
2013
Number of Employees (Ranges)
51 – 2009
Email Address
team@sequencebio.com8
Phone Number
+180029634818
Full Address
53 Bond Street, Suite 100 St. John's, NL, A1C 1S9 Canada8
Investors
Y Combinator
Y Combinator
2
Founded Date
2013
2
Glassdoor ID
4401025
Wellfound ID
sequence-bio
Country
Canada
Canada
8
Headquarters
St. John's, Newfoundland and Labrador
St. John's, Newfoundland and Labrador
8

Other attributes

Blog
blog.sequencebio.com
Company Operating Status
Active
Y Combinator URL
ycombinator.com/compani...ence-bio2

Biotechnology company combining genomic, multi-omic population data and longitudinal health records from the unique founder population of Newfoundland and Labrador, Canada to find drug targets. Sequence Bio makes use of Newfoundland and Labrador’s founder population and unique history as a cohort to explore to disease preventions and treatments. This population has a high rate of complex and inherited diseases which provides an opportunity to find underlying differences that affect disease and health. Findings are expected to improve the lives of people in Newfoundland and Labrador (NL) and around the world. One of the goals is the share research findings and integrate precision into their local healthcare system.

CEO Chris Gardner was appointed to the federal Health/Bio-sciences Economic Strategy Table by the Minister of Innovation, Science and Economic Development. CSO Michael S. Phillips previously held roles at Genomics Medicine Ireland and Merck. The company won the Community Impact and Business Excellence awards at the St. John’s Board of Trade Awards. Sequence Bio worked with Senator Jim Cowan to support passage of Bill S201 that ensures all Canadians are protected from genetic discrimination.

Sequence Bio is leading the NL Genome Project, a large-scale genomics research study that uses saliva samples for researching DNA combined with medical information in 2500 volunteers. Volunteers are enrolled at select doctor’s offices in the province.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date

Sequence Bio launches N.L. Genome Project

http://ntv.ca/sequence-bio-launches-n-l-genome-project/

July 24, 2019

References

Find more companies like Sequence Bio

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.